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Cheese whey poses a severe problem because of its high biological oxygen demand (35-
60 gL-1). Its valorization into secondary products such as whey protein concentrate 
(WPC) is considered to be profitable. The lactose content (50-60 gL-1) of the obtained 
cheese whey permeate makes it a suitable substrate for fermentation. Nevertheless, the 
economic success of this process depends on the development of high productivity 
systems. 
The aim of the present work was to contribute to the biotechnological improvement of 
cheese whey process treatment by the construction of lactose utilizing Saccharomyces 
cerevisiae flocculent strains. 
In a first approach, a high ethanol productivity process for the conversion of whey 
permeate into ethanol using an air-lift continuous system with flocculating yeast cells 
was developed. A flocculent S. cerevisiae strain with the ability to express both the 
LAC4 (coding for p-galactosidase) and LACJ2 (coding for lactose permease) genes of 
Kluyveromyces marxianus was constructed. This recombinant strain was used in a 
continuous high cell density system allowing for 11 gr1h-1 ethanol productivity 
(corresponding to a feed lactose concentration of 50 gr1 and a dilution rate of 0.55 h-1) 
which is 7 times larger than the continuous conventional systems. The use of cheese 
whey permeate as substrate was assayed resulting in an ethanol productivity of 10 gr'h-1 
for 0.45 h-1 dilution rate, which raises new perspectives for the economic feasibility of 
whey alcoholic fermentation. 
In a second approach, P-Galactosidase secreting flocculent and non-flocculent S. 
cerevisiae strains were constructed by cloning the Aspergillus niger lacA gene. One of 
the constructed strains presented p-galactosidase production comparable to the one 
achieved in commercial systems by fungi. The constructed strain was applied to a 
continuous high cell density system, allowing for a p-galactosidase productivity 6 times 
higher than the one obtained with the batch system. The cheese whey permeate and the 
cheese whey permeate concentrated were used as substrates and the produced enzyme 
was applied to the cheese whey permeate hydrolysis. 
